Biomoda and Clinical Research Center of Cape Cod Reach Agreement for Clinical Services
October 25th, 2007
Under a collection protocol approved by an Institutional Review Board, CRCCCÂ will collect and provide samples necessary for Biomoda’s commercialization program of its non-invasive sputum assay for the early detection of lung cancer. CRCCC is a leading medical research firm with products and services that support the pharmaceutical, biotechnology, diagnostic and genomics industries